Investigative Ophthalmology & Visual Science Cover Image for Volume 59, Issue 9
July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry
Alex Ferdi; Vuong Nguyen; Jeremy Tan; Yves Kerdraon; John Males; Nigel Morlet; Peter Beckinsale; Richard A Mills; Chris Go; Mark Daniell; Elsie Chan; Daniel Barthelmes; Amparo Herrera-Bond; Marco Garcia; Mark C Gillies; Stephanie L Watson
Author Affiliations & Notes
  • Alex Ferdi
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Vuong Nguyen
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Jeremy Tan
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Yves Kerdraon
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
    Sydney Eye Hospital, Sydney, New South Wales, Australia
  • John Males
    Sydney Eye Hospital, Sydney, New South Wales, Australia
  • Nigel Morlet
    University of Western Australia, Perth, Western Australia, Australia
  • Peter Beckinsale
    University of Queensland, Brisbane, Queensland, Australia
  • Richard A Mills
    Flinders University, Adelaide, South Australia, Australia
  • Chris Go
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Mark Daniell
    Centre for Eye Research Australia, Melbourne, Victoria, Australia
    Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia
  • Elsie Chan
    Centre for Eye Research Australia, Melbourne, Victoria, Australia
    Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia
  • Daniel Barthelmes
    University of Zurich, Zurich, Switzerland
  • Amparo Herrera-Bond
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Marco Garcia
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
  • Mark C Gillies
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
    Sydney Eye Hospital, Sydney, New South Wales, Australia
  • Stephanie L Watson
    Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
    Sydney Eye Hospital, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Alex Ferdi, None; Vuong Nguyen, None; Jeremy Tan, None; Yves Kerdraon, None; John Males, None; Nigel Morlet, None; Peter Beckinsale, None; Richard Mills, None; Chris Go, None; Mark Daniell, None; Elsie Chan, None; Daniel Barthelmes, None; Amparo Herrera-Bond, None; Marco Garcia, None; Mark Gillies, None; Stephanie Watson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4380. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Alex Ferdi, Vuong Nguyen, Jeremy Tan, Yves Kerdraon, John Males, Nigel Morlet, Peter Beckinsale, Richard A Mills, Chris Go, Mark Daniell, Elsie Chan, Daniel Barthelmes, Amparo Herrera-Bond, Marco Garcia, Mark C Gillies, Stephanie L Watson; The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4380.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose : To report the 12-month outcomes of 54 eyes undergoing corneal cross-linking (CXL) for keratoconus performed in 3 routine clinical practices in Australia.

Methods : Outcomes and adverse events were recorded prospectively in a custom-designed database, the Save Sight Keratoconus Registry. Index visit parameters, such as visual acuity (VA, in Logarithm of the Minimal Angle of Resolution [logMAR]), maximum keratometry [Kmax], steep keratometry [K2], pachymetry, as well as treatment parameters (epithelial status, riboflavin type, UV duration) were recorded. Index visit parameters associated with the 12-month VA outcome were identified using mixed effects linear regression.

Results : Median change in VA after 12 months was +4.5 logMAR letters (Quartiles 1 and 3 [Q1, Q3]: -4.8, 10.8); Kmax -0.3 D (Q1, Q3: -2.3, 0.4); K2 -0.2 (Q1, Q3: -1.4, 0.3) and pachymetry -14.0 microns (Q1, Q3: -23.8, -2.0). There was a significant improvement in VA (p = 0.048), reduction in Kmax (p = 0.027) and reduction in pachymetry at 12 months (p = 0.002). VA at the index visit was the strongest predictor for the 12-month VA outcomes (p < 0.001). There was no significant change in K2 at 12 months (p = 0.074).

Treatments were epithelial-off (n=54) with UV exposure that was accelerated (n= 40) or according to the Dresden protocol (n=14).

Adverse events occurred in 31 eyes and included corneal haze (27 eyes), microbial keratitis (1 eye), persistent epithelial defect (4 eyes), scarring (4 eyes), and sterile infiltrates (1 eye) from a total of 54 eyes within the first 12 months of follow-up. Haze was recorded in 7 eyes during the second year of follow-up. Eyes that experienced microbial keratitis or scarring within the first 12 months of follow-up had a median VA loss of -15 and -9 (Q1, Q3: -17.5, -2.25) letters at 12 months, respectively. Eyes that experienced haze, persistent epithelial defect or sterile infiltrates within the first 12 months of follow-up had a median VA change of +6 (Q1, Q3: -1, 11), +4 (Q1, Q3: 1.75, 6.0) and +0 letters at 12 months, respectively.

Conclusions : In routine clinical practice CXL can stabilize visual acuity and keratometric parameters. Although complications such as keratitis or scarring can result in visual loss, corneal haze does not appear to have a detrimental effect on visual outcomes at 12 months.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Attribution-NonCommercial-NoDerivatives
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept